3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
11
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
5
Triple Negative Breast Neoplasms
4
Neoplasms
4
Sarcoma
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Lymphoma
2
Liver Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Multiple Myeloma
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Interventions
pazopanib
2
cediranib
2
Sunitinib
2
Ifosfamide
2
Doxorubicin
2
sargramostim
1
romidepsin
1
pembrolizumab
1
indolepropanol phosphate
1
cabozantinib
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
Watchful Waiting
1
Warfarin
1
Vitamin B 6
1
Thyroxine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Pyridoxine
1
Promethazine
1
Prochlorperazine
1
Polymerase Chain Reaction
1
Petrolatum
1
Observation
1
Neoadjuvant Therapy
1
Lorazepam
1
Loperamide
1
HhAntag691
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Alveolar Soft Part
×
spartalizumab
×
Clear all
No trials found.